Myriad Genetics and Abbott Laboratories Form Drug Discovery Collaboration
- Alliance to Focus on Discovery of Drugs to Treat Depression -
13-Mar-2002 -
SALT LAKE CITY, Mar 12, 2002
Myriad Genetics, Inc., announced today that it has formed a drug discovery collaboration with Abbott Laboratories to identify novel genes and drug targets for the diagnosis and treatment of depression. The collaboration will merge Myriad's integrated drug target ...
Abbott
depressions
drug discovery collaborations
+6